Product Description
Fluticasone propionate ≥97.0% Hormone API made in china 80474-14-2
AI Product Description
*The following content is generated by AI and is for reference only.
Fluticasone propionate, a high-purity corticosteroid with an assay of ≥97.0%, is a premier pharmaceutical ingredient manufactured in China for global distribution. This active pharmaceutical ingredient (API) belongs to the class of synthetic glucocorticoids and is widely recognized for its potent anti-inflammatory and antipruritic properties. The chemical structure of Fluticasone propionate is defined by the molecular formula C25H31FO5S, accompanied by the CAS Registry Number 80466-40-2. Its unique molecular architecture includes a difluorinated steroid backbone and a thioether linkage, which significantly enhances its receptor affinity while minimizing systemic bioavailability when administered via inhalation or topical routes.
The primary clinical applications of this API involve the management of respiratory conditions such as asthma and allergic rhinitis. As a component of various inhalers and nasal sprays, it effectively reduces airway inflammation, alleviates bronchoconstriction, and improves overall lung function without causing significant adrenal suppression at therapeutic doses. Furthermore, due to its high potency, it is utilized in dermatological formulations to treat inflammatory skin disorders like eczema, psoriasis, and contact dermatitis. The Chinese manufacturing sector has established robust production capabilities for this compound, ensuring strict adherence to international Good Manufacturing Practices (GMP) and quality standards required by regulatory bodies such as the FDA and EMA.
Manufacturers emphasize that Fluticasone propionate produced in China offers competitive pricing alongside consistent batch-to-batch purity, making it a preferred choice for generic drug developers and major pharmaceutical companies worldwide. The product undergoes rigorous testing to confirm its identity, potency, and absence of impurities, guaranteeing safety and efficacy for end-users. Its versatility extends beyond human medicine into veterinary applications for managing similar inflammatory conditions in animals. As the demand for effective respiratory and skin therapies continues to grow globally, Fluticasone propionate remains a cornerstone molecule in modern pharmacotherapy, bridging the gap between advanced chemical synthesis and essential patient care solutions across diverse medical landscapes.